Accueil
»
Bourse
»
Actions Paris
»

Consensus des Analystes Bastide Le Confort Medical

Cotation du 15/01/2021 à 17h39 Bastide Le Confort Medical +5,10% 57,700€

Objectif de cours au 17/01/2021

54,825 €
Potentiel atteint
cours actuel 57,700€

Note médiane des 5 analystes

1,6
5 Vendre 4 Alléger 3 Conserver 2 Renforcer 1 Acheter

Evolution des recommandations

Recommandations 17/01/2020 17/04/2020 17/07/2020 17/10/2020 17/01/2021
Acheter 3 3 3 2 2
Renforcer - - 1 2 3
Conserver 2 2 1 1 -
Alléger - - - - -
Vendre - - - - -
Nb d'analystes 5 5 5 5 5
Note Médiane 1,80 1,80 1,60 1,80 1,60
Historique des objectifs 45,780€ 42,680€ 39,625€ 44,350€ 54,825€

Prévisions

2020 2021 2022
Chiffre d'affaires 382,71 423,17 443,06
EBITDA 81,39 91,48 94,98
EBIT 32,76 36,93 42,30
Résultat Net 11,60 17,79 20,41
Flux de trésorerie disponible 7,54 41,40 28,97
Dette nette 270,87 197,72 167,14
PER 34,85 23,22 21,27
Copyright ©2021, S&P Global Market Intelligence. Reproduction of CIQ Estimates in any form is prohibited except with the prior written permission of S&P Global Market Intelligence. CIQ Estimates are not investment advice and a reference to a particular investment or security, a credit rating or any observation concerning a security or investment provided in CIQ Estimates is not a recommendation to buy, sell or hold such investment or security or make any other investment decisions. S&P Global Market Intelligence, its affiliates and their third-party providers (together, “S&P Global”) do not guarantee the accuracy, adequacy, completeness or availability of any information and are not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P GLOBAL DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P Global be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of CIQ Estimates.